Impaired NK cell differentiation of blood-derived CD34+ progenitors from patients with myeloid metaplasia with myelofibrosis

被引:16
作者
Briard, D
Brouty-Boyé, D
Giron-Michel, J
Azzarone, B
Jasmin, C
Le Bousse-Kerdilès, MC
机构
[1] Hop Paul Brousse, INSERM, U 268, F-94807 Villejuif, France
[2] Hop Paul Brousse, INSERM, U506, F-94807 Villejuif, France
基金
澳大利亚研究理事会;
关键词
myeloid metaplasia with myelofibrosis; blood CD34(+) cells; NK cell differentiation; IL-15; fibroblast; signaling pathway;
D O I
10.1016/S1521-6616(02)00046-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cultured blood CD34(+) progenitors from patients with myeloid metaplasia with myelofibrosis (MMM) failed to differentiate into natural killer (NK) cells with recombinant interleukin (IL)-15. No NK cells either could be induced in coculture with IL-15-expressing fibroblasts from MMM patients' spleens. The impaired NK differentiation could be circumvented by using normal blood CD34(+) cells in the coculture. In this case, cell-to-cell contact and IL-15 interaction were crucial for NK cell differentiation. Pretreatment of normal CD34(+) progenitors with anti-IL-15 monoclonal antibody markedly reduced NK cell production while MMM fibroblast pretreatment did not. Both normal and MMM progenitors constitutively expressed IL-15. Analysis of endogenous IL-15 signaling pathway revealed a constitutive gammac/Jak3 association and STAT3 activation in the two types of progenitors. Anti-IL-15 monoclonal antibody treatment caused a downregulation of IL-15 signaling in normal but not MMM blood cells. The impaired NK differentiation in MMM may thus arise from a deregulated control of an endogenous IL-15 involved in hematopoietic progenitors' lymphoid differentiation. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:201 / 212
页数:12
相关论文
共 18 条
[1]   Fibroblasts from human spleen regulate NK cell differentiation from blood CD34+ progenitors via cell surface IL-15 [J].
Briard, D ;
Brouty-Boyé, D ;
Azzarone, B ;
Jasmin, C .
JOURNAL OF IMMUNOLOGY, 2002, 168 (09) :4326-4332
[2]   Effects of human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues on CD34+ stem cells [J].
Brouty-Boyé, D ;
Briard, D ;
Azzarone, B ;
Le Bousse-Kerdilès, MC ;
Clay, D ;
Pottin-Clémenceau, C ;
Jasmin, C .
INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (04) :484-488
[3]  
Brouty-Boyé D, 1998, INT J CANCER, V76, P767, DOI 10.1002/(SICI)1097-0215(19980529)76:5<767::AID-IJC24>3.0.CO
[4]  
2-#
[5]  
Carayol G, 1998, EUR J IMMUNOL, V28, P1991, DOI 10.1002/(SICI)1521-4141(199806)28:06<1991::AID-IMMU1991>3.0.CO
[6]  
2-7
[7]   Altered natural killer cell differentiation in CD34+ progenitors from chronic myeloid leukemia patients [J].
Carayol, G ;
Giron-Michel, J ;
Azzarone, B ;
Castagna, L ;
Cambier, N ;
Mishal, Z ;
Bourhis, JH ;
Chouaib, S ;
Caignard, A .
ONCOGENE, 2000, 19 (23) :2758-2766
[8]   Assessment of peripheral blood lymphocyte subsets in idiopathic myelofibrosis [J].
Cervantes, F ;
Hernández-Boluda, JC ;
Villamor, N ;
Serra, A ;
Montserrat, E .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 65 (02) :104-108
[9]   HUMAN T-CELLS, B-CELLS, NATURAL-KILLER, AND DENDRITIC CELLS ARISE FROM A COMMON BONE-MARROW PROGENITOR-CELL SUBSET [J].
GALY, A ;
TRAVIS, M ;
CEN, DZ ;
CHEN, B .
IMMUNITY, 1995, 3 (04) :459-473
[10]   Phenotypic, molecular, and functional characterization of human peripheral blood CD34(+)/Thy1(+) cells [J].
Humeau, L ;
Bardin, F ;
Maroc, C ;
Alario, T ;
Galindo, R ;
Mannoni, P ;
Chabannon, C .
BLOOD, 1996, 87 (03) :949-955